Transdermal physostigmine in the treatment of Alzheimer's disease.
Levy A, Brandeis R, Treves TA, Meshulam Y, Mawassi F, Feiler D, Wengier A, Glikfeld P, Grunwald J, Dachir S, et al.
Levy A, et al. Among authors: grunwald j.
Alzheimer Dis Assoc Disord. 1994 Spring;8(1):15-21. doi: 10.1097/00002093-199408010-00004.
Alzheimer Dis Assoc Disord. 1994.
PMID: 8185877
Clinical Trial.